According to Seres Therapeutics's latest financial reports the company's current earnings (TTM) are -โฌ0.14 B. In 2023 the company made an earning of -โฌ90.74 M an increase over its 2022 earnings that were of -โฌ0.23 B.The earnings displayed on this page is the company's Pretax Income.